Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated cardiomyopathy

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 2, 2008, Pages

  Ruppert, Volker ^a   Meyer, Thomas ^a   Pankuweit, Sabine ^a   Möller, Eva ^b   Funck, Reinhard C ^a   Grimm, Wolfram ^a   Maisch, Bernhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b SIRS Lab GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TOLL LIKE RECEPTOR 9;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MYOCARDITIS; PERICARDITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 48849116625     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.03.016     Document Type: Article

References (32)

1. Pisani B., Taylor D.O., and Mason J.W. Inflammatory myocardial diseases and cardiomyopathies. Am J Med 102 (1997) 459-469
2. Magnani J.W., and Dec G.W. Myocarditis. Current trends in diagnosis and treatment. Circulation 113 (2006) 876-890
3. Maisch B., Richter A., Kölsch S., Alter P., Funck R., and Pankuweit S. Management of patients with suspected (peri-)myocarditis and inflammatory dilated cardiomyopathy. Herz 31 (2006) 881-890
4. Pankuweit S., Moll R., Baandrup U., Portig I., Hufnagel G., and Maisch B. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 34 (2003) 497-503
5. Kühl U., Pauschinger M., Noutsias M., Seeberg B., Bock T., Lassner D., et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic "left ventricular dysfunction. Circulation 111 (2005) 887-893
6. Mahrholdt H., Wagner A., Deluigi C.C., Kispert E., Hager S., Meinhardt G., et al. Presentation, patterns of myocardial damage, and clinical couse of viral myocarditis. Circulation 114 (2006) 1581-1590
7. Ardehali H., Qasim A., Cappola T., Howard D., Hruban R., Hare J.M., et al. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am Heart J 147 (2004) 919-923
8. Mills R.M., and Lauer M.S. Endomyocardial biopsy: a procedure in search of an indication. Am Heart J 147 (2004) 759-760
9. Aretz H.T., Billingham M.E., Edwards W.D., Factor S.M., Fallon J.T., Fenoglio J.J., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1 (1987) 3-14
10. Herskowitz A., Campbell S., Deckers J., Kasper E.K., Boehmer J., Hadian D., et al. Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy. Am J Cardiol 71 (1993) 982-986
11. Zimmermann O., Kochs M., Zwaka T.P., Kaya Z., Lepper P.M., Bienek-Ziolkowski M., et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. Int J Cardiol 104 (2005) 92-100
12. Cook S.A., and Rosenzweig A. DNA microarrays. Implications for cardiovascular medicine. Circ Res 91 (2002) 559-564
13. Perrot A., Kabaeva Z., Wenzel K., and Osterziel K.J. Gene expression analysis of human tissue from patients with cardiomyopathies: a new tool for guiding therapies in the future?. J Card Surg 20 (2005) S17-S19
14. Nanni L., Romualdi C., Maseri A., and Lanfranchi G. Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. J Mol Cell Cardiol 41 (2006) 934-948
15. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93 (1996) 841-842
16. Maisch B., Richter A., Sandmöller A., Portig I., Pankuweit S., and BMBF-Heart Failure Network. Inflammatory dilated cardiomyopathy. Herz 30 (2005) 535-544
17. Huber W., von Heydebreck A., Sueltmann H., Poustka A., and Vingron M. Parameter estimation for the calibration and variance stabilization of microarray data. Stat Appl Genet Mol Biol 2 (2003) Article 3
18. Troyanskaya O., Cantor M., Sherlock G., Brown P., Hastie T., Tibshirani R., et al. Missing value estimation methods for DNA microarrays. Bioinformatics 17 (2001) 520-525
19. Storey J.D., and Tibshirani R. Statistical significance for genome-wide studies. Proc Natl Acad Sci U S A 100 (2003) 9440-9445
20. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
21. 2+-exchanger compensate the negative inotropic effects of downregulated SERCA?. Cardiovasc Res 49 (2001) 1-6
22. Sehl P.D., Tai J.T.N., Hillan K.J., Brown L.A., Goddard A., Yang R., et al. Application of cDNA Microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation 101 (2000) 1990-1999
23. Yang J., Moravec C.S., Sussman M.A., DiPaola N.R., Fu D., Hawthorn L., et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102 (2000) 3046-3052
24. Barrans J.B., Allen P.D., Stamatiou D., Dzau V.J., and Liew C.C. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol 160 (2002) 2035-2043
25. Hwang J.J., Allen P.D., Tseng G.C., Lam C.W., Fananapazir L., Dzau V.J., and Liew C.C. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 10 (2002) 31-44
26. Grzeskowiak R., Witt H., Drungowski M., Thermann R., Hennig S., Perrot A., et al. Expression profiling of human dilated cardiomyopathy. Cardiovasc Res 59 (2003) 400-411
27. Steenbergen C., Afshari C.A., Petranka J.G., Collins J., Martin K., Bennett L., et al. Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure. Am J Physiol Heart Circ Physiol 284 (2003) H268-H276
28. Kääb S., Barth A.S., Margerie D., Dugas M., Gebauer M., Zwermann L., et al. Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. J Mol Med 82 (2004) 308-316
29. Yung C.K., Halperin V.L., Tomaselli G.F., and Winslow R.L. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy. Altered expression of apoptotic and cytoskeletal genes. Genomics 83 (2004) 281-297
30. Kittleson M.M., Minhas K.M., Irizarry R.A., Ye S.Q., Edness G., Breton E., et al. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics 21 (2005) 299-307
31. Margulies K.B., Matiwala S., Cornejo C., Olsen H., Craven W.A., and Bednarik D. Mixed messages. Transription patterns in failing and recovering human myocardium. Circ Res 96 (2005) 592-599
32. de Kleijn D., and Pasterkamp G. Toll-like receptors in cardiovascular diseases. Cardiovasc Res 60 (2003) 58-67